| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.041 | 0.3 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |